Wilkerson Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Sell
3,053
-592
-16% -$69.3K 0.12% 72
2026
Q1
$438K Buy
3,645
+2,804
+333% +$324K 0.15% 58
2025
Q4
$88.5K Buy
+841
New +$78.9K 0.03% 126

Other funds holding MRK

Wilkerson Advisory Group's MRK Position: Q2 2026 in Review

Wilkerson Advisory Group reduced its Merck (MRK) stake by 16% in Q2 2026, selling an estimated $69.3K and leaving 3,053 shares worth $392K. The position accounts for 0.12% of the portfolio, ranked #72.

Wilkerson Advisory Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $438K in Q1 2026. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wilkerson Advisory Group held 3,053 shares of Merck worth $392K as of Q2 2026.
  • Wilkerson Advisory Group sold 592 Merck shares in Q2 2026, an estimated $69.3K.
  • Merck made up 0.12% of Wilkerson Advisory Group's portfolio in Q2 2026, its #72 holding.
  • Wilkerson Advisory Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Wilkerson Advisory Group's Merck position peaked at $438K in Q1 2026.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.